Tradestie Institutional Equity Comparison Engine

BSLK vs VTAK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-10-02 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VTAK Overall Edge

VTAK Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Catheter Precision, Inc. (VTAK) driven by superior Growth & Margin, Momentum & Technical while BSLK counters with relative strength in Valuation. Fundamentally, BSLK trades at N/M Forward P/E with -1179.5% operating margin (+7300.0% YoY revenue) versus VTAK at N/M Forward P/E and -388.1% operating margin (+380.7% YoY). In options structure, BSLK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VTAK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner BSLK
BSLK N/M vs VTAK N/M Fwd P/E
Growth & Margin Winner VTAK
Op Margin -1179.5% vs -388.1% ยท YoY +7300.0% vs +380.7%
Momentum & Technical Winner VTAK
1Y -94.4% vs -94.3% ยท 52W Pos 0% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BSLK NASDAQ
Bolt Projects Holdings, Inc. Common Stock
Industrial Organic Chemicals
$0.58
-27.01% 1D
Market Cap $7.1M
1M Return -73.85%
1Y Return -94.42%
Forward P/E N/M
Unified AI Score
41.2 / 100 SELL
Tech 40.0 Fund 43.0 Flow 50.0 Mom 40.0
VTAK NYSE American
Catheter Precision, Inc.
Surgical & Medical Instruments & Apparatus
$0.15
-0.66% 1D
Market Cap $548,639
1M Return -24.76%
1Y Return -94.28%
Forward P/E N/M
Unified AI Score
58.1 / 100 HOLD
Tech 72.0 Fund 70.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BSLK -94.42% VTAK -94.28% Spread: +62.22 pp (VTAK Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BSLK Revenue VTAK Revenue BSLK Op. Margin VTAK Op. Margin Margin Edge
Q1 '25 $0M $0M -3157.9% -2416.8% VTAK
Q2 '25 $10M $0M -370.0% -1338.7% BSLK
Q3 '25 $0M $0M -1179.5% -1336.7% BSLK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BSLK (2) vs VTAK (4)
Institutional Metric BSLK VTAK Criterion Row Winner
Market Capitalization Scale $7.1M $548,639 Larger Scale Tie
Trailing P/E Ratio Valuation 0.1x N/M Lower Multiple BSLK
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +7300.0% +380.7% Higher Growth BSLK
Operating Margin (TTM) Profitability -1179.5% -388.1% Higher Margin VTAK
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -4288.3% -111.3% Higher ROE VTAK
52-Week Range Position Momentum 0% ($1โ€“$25) 1% ($0โ€“$3) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 4.04ฮฒ ยท 148% Vol 0.19ฮฒ ยท 76% Vol Lower Realized Risk VTAK
Unified Institutional Score Composite Signal 41.2 / 100 (SELL) 58.1 / 100 (HOLD) Higher Composite VTAK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BSLK vs VTAK Buy Guide
BSLK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BSLK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VTAK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VTAK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BSLK nor VTAK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.